Patent Filing – Germany 2022 - JUVE Patent
Thomas Kabel - CFO at 21st.BIO | The Org
Annual Report 2017
Thomas Kabel - CFO at 21st.BIO | The Org
Patent Filing – Germany 2020 - JUVE Patent
Patent Filing – Germany 2020 - JUVE Patent
Thomas Kabel - CFO at 21st.BIO | The Org
PDF) Characterizing visible and invisible cell wall mutant phenotypes
Thomas T. Kabel | LinkedIn
Thomas Kabel - CFO at 21st.BIO | The Org
Gréta Gecse på LinkedIn: #fbm #dtu #biomanufacturing #fermentation
Characterizing visible and invisible cell wall mutant phenotypes
John Brett Theroux - Roller i dansk erhvervsliv
Annual Report 2017
Thomas Kabel - CFO at 21st.BIO | The Org
PDF) Characterizing visible and invisible cell wall mutant phenotypes
Glycom GmbH, Hamburg
PDF) Combinatorial Glycomic Analyses to Direct CAZyme Discovery for the Tailored Degradation of Canola Meal Non-Starch Dietary Polysaccharides
Nyt fra bestyrelseslokaler og direktionsgange
Thomas T. Kabel | LinkedIn
PDF) Combinatorial Glycomic Analyses to Direct CAZyme Discovery for the Tailored Degradation of Canola Meal Non-Starch Dietary Polysaccharides
Patent Filing – Germany 2020 - JUVE Patent
Characterizing visible and invisible cell wall mutant phenotypes
PDF) Combinatorial Glycomic Analyses to Direct CAZyme Discovery for the Tailored Degradation of Canola Meal Non-Starch Dietary Polysaccharides
Patent Filing – Germany 2020 - JUVE Patent
